Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 10.88 HKD -6.85% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Intrinsic Value

The intrinsic value of one Genscript Biotech Corp stock under the Base Case scenario is 32.38 HKD. Compared to the current market price of 10.88 HKD, Genscript Biotech Corp is Undervalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
32.38 HKD
Undervaluation 66%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genscript Biotech Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Genscript Biotech Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Genscript Biotech Corp?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Genscript Biotech Corp

Provide an overview of the primary business activities
of Genscript Biotech Corp.

What unique competitive advantages
does Genscript Biotech Corp hold over its rivals?

What risks and challenges
does Genscript Biotech Corp face in the near future?

Summarize the latest earnings call
of Genscript Biotech Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genscript Biotech Corp.

Provide P/S
for Genscript Biotech Corp.

Provide P/E
for Genscript Biotech Corp.

Provide P/OCF
for Genscript Biotech Corp.

Provide P/FCFE
for Genscript Biotech Corp.

Provide P/B
for Genscript Biotech Corp.

Provide EV/S
for Genscript Biotech Corp.

Provide EV/GP
for Genscript Biotech Corp.

Provide EV/EBITDA
for Genscript Biotech Corp.

Provide EV/EBIT
for Genscript Biotech Corp.

Provide EV/OCF
for Genscript Biotech Corp.

Provide EV/FCFF
for Genscript Biotech Corp.

Provide EV/IC
for Genscript Biotech Corp.

Show me price targets
for Genscript Biotech Corp made by professional analysts.

What are the Revenue projections
for Genscript Biotech Corp?

How accurate were the past Revenue estimates
for Genscript Biotech Corp?

What are the Net Income projections
for Genscript Biotech Corp?

How accurate were the past Net Income estimates
for Genscript Biotech Corp?

What are the EPS projections
for Genscript Biotech Corp?

How accurate were the past EPS estimates
for Genscript Biotech Corp?

What are the EBIT projections
for Genscript Biotech Corp?

How accurate were the past EBIT estimates
for Genscript Biotech Corp?

Compare the revenue forecasts
for Genscript Biotech Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genscript Biotech Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genscript Biotech Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genscript Biotech Corp compared to its peers.

Compare the P/E ratios
of Genscript Biotech Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Genscript Biotech Corp with its peers.

Analyze the financial leverage
of Genscript Biotech Corp compared to its main competitors.

Show all profitability ratios
for Genscript Biotech Corp.

Provide ROE
for Genscript Biotech Corp.

Provide ROA
for Genscript Biotech Corp.

Provide ROIC
for Genscript Biotech Corp.

Provide ROCE
for Genscript Biotech Corp.

Provide Gross Margin
for Genscript Biotech Corp.

Provide Operating Margin
for Genscript Biotech Corp.

Provide Net Margin
for Genscript Biotech Corp.

Provide FCF Margin
for Genscript Biotech Corp.

Show all solvency ratios
for Genscript Biotech Corp.

Provide D/E Ratio
for Genscript Biotech Corp.

Provide D/A Ratio
for Genscript Biotech Corp.

Provide Interest Coverage Ratio
for Genscript Biotech Corp.

Provide Altman Z-Score Ratio
for Genscript Biotech Corp.

Provide Quick Ratio
for Genscript Biotech Corp.

Provide Current Ratio
for Genscript Biotech Corp.

Provide Cash Ratio
for Genscript Biotech Corp.

What is the historical Revenue growth
over the last 5 years for Genscript Biotech Corp?

What is the historical Net Income growth
over the last 5 years for Genscript Biotech Corp?

What is the current Free Cash Flow
of Genscript Biotech Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genscript Biotech Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genscript Biotech Corp

Current Assets 2.4B
Cash & Short-Term Investments 1.9B
Receivables 299.5m
Other Current Assets 125.5m
Non-Current Assets 1B
Long-Term Investments 90.8m
PP&E 750.9m
Intangibles 20m
Other Non-Current Assets 172.4m
Current Liabilities 494.8m
Accounts Payable 40m
Accrued Liabilities 165.9m
Short-Term Debt 56.9m
Other Current Liabilities 232m
Non-Current Liabilities 1.5B
Long-Term Debt 351.1m
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
Genscript Biotech Corp

Revenue
1B USD
Cost of Revenue
-468.1m USD
Gross Profit
541.5m USD
Operating Expenses
-936.5m USD
Operating Income
-395m USD
Other Expenses
218m USD
Net Income
-177m USD

Free Cash Flow Analysis
Genscript Biotech Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The company's administrative expenses spiked, driven primarily by its U.S. plasmid facility costs. ProBio's projected full-year revenue growth is in the low single digits with consistent gross profit margins. Bestzyme achieved a nearly 9% revenue increase, with expectations for a full-year growth of 20%-30%, and stable gross profit margins around 40%. The firm's cash position reached $1.5 billion after raising $785 million, anticipating sufficient funds for the next two years.

What is Earnings Call?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Genscript Biotech Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROIC is Increasing
33/100
Profitability
Score

Genscript Biotech Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Genscript Biotech Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
68/100
Solvency
Score

Genscript Biotech Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Genscript Biotech Corp

Wall Street analysts forecast Genscript Biotech Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 25.23 HKD with a low forecast of 16.16 HKD and a high forecast of 31.5 HKD.

Lowest
Price Target
16.16 HKD
49% Upside
Average
Price Target
25.23 HKD
132% Upside
Highest
Price Target
31.5 HKD
190% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Genscript Biotech Corp?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Genscript Biotech Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Genscript Biotech Corp Logo
Genscript Biotech Corp

Country

China

Industry

Life Sciences Tools & Services

Market Cap

23.1B HKD

Dividend Yield

0%

Description

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2015-12-30. The firm operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.

Contact

JIANGSU
Nanjing
No. 28, Yongxi Road, Jiangning Science Park
www.genscript.com

IPO

2015-12-30

Employees

4 558

Officers

Executive Chairman
Mr. Jiange Meng
CEO & COO
Ms. Weihui Shao
Co-Founder, President & Executive Director
Ms. Ye Wang M.S.
Co-Founder & Non-Executive Director
Dr. Luquan Wang
Chief Financial Officer
Mr. Shiniu Wei
Co-Founder & Executive Director
Dr. Fangliang Zhang EMBA, Ph.D.
Show More
Chief Strategy Officer & Executive Director
Dr. Li Zhu Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one Genscript Biotech Corp stock?

The intrinsic value of one Genscript Biotech Corp stock under the Base Case scenario is 32.38 HKD.

Is Genscript Biotech Corp stock undervalued or overvalued?

Compared to the current market price of 10.88 HKD, Genscript Biotech Corp is Undervalued by 66%.

Back to Top